Fattore di trascrizione ICBP90
Lorenzato M, CaudroyS, Bronner C, Evrard G, Simon M, Durlach A, Birembaut P, Clavel C. Cell cycle and/or proliferation markers: what is the best method to discriminate cervical high-grade lesions? Hum Pathol. 2005 Oct;36(10):1101-7.
Jeanblanc M, Mousli M, Hopfner R, Bathami K, Martinet N, Abbady AQ, Siffert JC, Mathieu E, Muller CD, Bronner C. The retinoblastoma gene and its product are targeted by ICBP90: a key mechanism in the G1/S transition during the cell cycle. Oncogene. 2005 Nov 10;24(49):7337-45.
Abbady AQ, Bronner C, Bathami K, Muller CD, Jeanblanc M, Mathieu E, Klein JP, Candolfi E, Mousli M. TCR pathway involves ICBP90 gene down-regulation via E2F binding sites. Biochem Pharmacol. 2005 Aug 15;70(4):570-9.
Bronner C, Trotzier MA, Filhol O, Cochet C, Rochette-Egly C, Scholler-Guinard M, Klein JP, Mousli M. The antiapoptotic protein ICBP90 is a target for protein kinase 2. Ann N Y Acad Sci. 2004 Dec;1030:355-60. Unoki M, Nishidate T, Nakamura Y. ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain. Oncogene. 2004 Oct 7;23(46):7601-10.
Trotzier MA, Bronner C, Bathami K, Mathieu E, Abbady AQ, Jeanblanc M, Muller CD, Rochette-Egly C, Mousli M. Phosphorylation of ICBP90 by protein kinase A enhances topoisomerase IIalpha expression. Biochem Biophys Res Commun. 2004 Jun 25;319(2):590-5
Hopfner R, Mousli M, Jeltsch JM, Voulgaris A, Lutz Y, Marin C, Bellocq JP, Oudet P and Bronner C. ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression. Cancer Res 60, 121-128, 2000.
Hopfner R, Mousli M, Garnier JM, Redon R, Du Manoir S, Chatton B, Ghyselinck N, Oudet P and Bronner C. Genomic structure and chromosomal mapping of the gene coding for ICBP90, a protein involved in the regulation of the topoisomerase IIalpha gene expression. Gene 266, 15-23, 2001.
Bronner C, Hopfner R, and Mousli M. Transcriptional Regulation of the Human Topoisomerase IIalpha gene. Anticancer Res 22 (2A), 605-612, 2002.
Hopfner R, Mousli M, Oudet P and Bronner C. Overexpression of ICBP90, a novel CCAAT-binding protein, overcomes cell contact inhibition by forcing topoisomerase IIalpha expression. Anticancer Res 22(6A), 3165-3170, 2002.
Mousli M, Hopfner R, Abbady AQ, Monte D, Jeanblanc M, Oudet P, Louis B, Bronner C. ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells. Br J Cancer 89 (1), 120-127, 2003.
Abbady AQ, Bronner C, Trotzier MA, Hopfner R, Bathami K, Muller CD, Jeanblanc M and Mousli M. ICBP90 expression is downregulated in apoptosis-induced jurkat cells. Ann. NY Acad. Sci. 1010, 300-303, 2003.
Arima Y, Hirota T, Bronner C, Mousli M, Fujiwara T, Niwa S-I, Ishikawa H, Saya H . Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition. Genes to Cells 9 (2), 131-142, 2004.